NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Stable Coronary Artery Disease
Date of first enrollment	23/06/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Ticagrelor INN of investigational material : Ticagrelor Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : Oral treatment control material(s) Generic name etc : Clopidogrel INN of investigational material : Clopidogrel Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : Oral treatment

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 80age old
Gender	Both
Include criteria	- Any Percutaneous Coronary Intervention, more than 3 months prior to randomization or Previous documented acute coronary syndrome (ACS), more than 3 months prior to randomisation - Treatment with ASA
Exclude criteria	- ACS, transient ischemic attack (TIA), or Stroke within the 3 months prior to randomisation - Known concurrent disease of stroke or TIA with atrial fibrillation - Persons who are being treated with blood clotting agents that cannot be stopped